AHB(SH:688639) Zhi Tong Cai Jing·2025-11-14 12:20Group 1 - The China Securities Regulatory Commission (CSRC) has requested Huaheng Biological (688639.SH) to provide supplementary information regarding its technology export business and compliance over the past three years [1] - Huaheng Biological has submitted a listing application to the Hong Kong Stock Exchange, with Huatai International as the sole sponsor [1] - The CSRC has outlined specific areas for Huaheng Biological to clarify, including the status of its technology export business, compliance with regulations, and the use of raised funds for overseas investments [1] Group 2 - Huaheng Biological is a pioneer in synthetic biology, focusing on the research, large-scale production, and commercialization of bio-based products [2] - The company is recognized as one of the most comprehensive enterprises globally in commercial applications of bio-based products through synthetic biology [2] - Huaheng Biological is the first company to industrialize the anaerobic fermentation of a series of amino acids, including L-Alanine and L-Valine, and holds the largest market share for these products globally as of 2024 [2]